Metraipolis › archive › dc_2f7fbbc2d944

Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study — Europe PMC PMID:41583427

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41583427
DOI
10.3389/fimmu.2025.1701319
License (as archived)
solo-consultazione
Archived
2026-11-06T22:46:27.526Z
SHA-256 of the archived text
8c30457b63dff008e646393759b1dae74a441a648eb3a991efda6ac45bc43d1e
Stable URL of this page
https://metraipolis.com/documento/dc_2f7fbbc2d944

How to cite

Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study — Europe PMC PMID:41583427 — Europe PMC (en), https://europepmc.org/article/MED/41583427 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f7fbbc2d944 (Metraipolis archive dc_2f7fbbc2d944, sha256 8c30457b63dff008e646393759b1dae74a441a648eb3a991efda6ac45bc43d1e)
BibTeX
@misc{dc2f7fbbc2d944,
  title = {Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study — Europe PMC PMID:41583427},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41583427},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f7fbbc2d944; sha256 8c30457b63dff008e646393759b1dae74a441a648eb3a991efda6ac45bc43d1e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41583427. Agents can read the archived copy with the MCP tool read_document.